Diagnosis and management of infectious pleural effusion

Treatments in Respiratory Medicine

Volumn 5, Issue 5, 2006, Pages 295-304

  Rahman, Najib M ^a,b   Chapman, Stephen J ^a   Davies, Robert J O ^a  

^a Oxford Centre for Respiratory Medicine   (United Kingdom)

^b CHURCHILL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOPENICILLIN; ANTIBIOTIC AGENT; BETA LACTAMASE INHIBITOR; CEPHALOSPORIN; CLINDAMYCIN; FIBRINOLYTIC AGENT; METRONIDAZOLE; QUINOLONE DERIVATIVE; STREPTOKINASE; ANTIINFECTIVE AGENT;

ABSCESS DRAINAGE; ARTICLE; BACTERIUM CULTURE; CANDIDA; CELL COUNT; CHEMICAL ANALYSIS; CLINICAL FEATURE; DECORTICATION; EMPYEMA; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HOSPITAL INFECTION; HUMAN; LABORATORY TEST; LONG TERM CARE; MORBIDITY; MORTALITY; MYCOBACTERIUM TUBERCULOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; NURSING CARE; NUTRITION; PATHOGENESIS; PH MEASUREMENT; PLEURA EFFUSION; PLEURA FLUID; PNEUMONIA; PRIORITY JOURNAL; THORACOTOMY; THORAX RADIOGRAPHY; UNITED KINGDOM; UNITED STATES; DRAINAGE; EMPYEMA, PLEURAL; FIBRINOLYTIC THERAPY; PLEURA DISEASE; PLEURAL EFFUSION;

ANTI-BACTERIAL AGENTS; DRAINAGE; EMPYEMA, PLEURAL; FIBRINOLYTIC AGENTS; HUMANS; PLEURAL DISEASES; PLEURAL EFFUSION; THROMBOLYTIC THERAPY;

EID: 33748086043     PISSN: 11763450     EISSN: 11763450     Source Type: Journal    
DOI: 10.2165/00151829-200605050-00001     Document Type: Article

References (53)

1. Ferguson AD, Prescott RJ, Selkon JB, et al. The clinical course and management of thoracic empyema. QJM 1996; 89 (4): 285-9
2. Maskell NA, Davies CW, Nunn AJ, et al. UK controlled trial of intrapleural streptokinase for pleural infection. N Engl J Med 2005; 352 (9): 865-74
3. Hamm H, Light RW. Parapneumonic effusion and empyema. Eur Respir J 1997; 10 (5): 1150-6
4. BTS Guidelines for the management of community acquired pneumonia in adults. British Thoracic Society Standards of Care Committee. Thorax 2001; 56 Suppl 4: IV1-64
5. Light RW, Girard WM, Jenkinson SG, et al. Parapneumonic effusions. Am J Med 1980; 69 (4): 507-12
6. Sahn SA. Management of complicated parapneumonic effusions. Am Rev Respir Dis 1993; 148 (3): 813-7
7. Davies CW, Kearney SE, Gleeson FV, et al. Predictors of outcome and long-term survival in patients with pleural infection. Am J Respir Crit Care Med 1999; 160 (5 Pt 1): 1682-7
8. Eastham KM, Freeman R, Kearns AM, et al. Clinical features, aetiology and outcome of empyema in children in the north east of England. Thorax 2004; 59 (6): 522-5
9. Brook I, Frazier EH. Aerobic and anaerobic microbiology of empyema: a retrospective review in two military hospitals. Chest 1993; 103 (5): 1502-7
10. Smith JA, Mullerworth MH, Westlake GW, et al. Empyema thoracis: 14-year experience in a teaching center. Ann Thorac Surg 1991; 51 (1): 39-42
11. Davies CW, Gleeson FV, Davies RJ. BTS guidelines for the management of pleural infection. Thorax 2003; 58 Suppl. 2: ii18-28
12. Kroegel C, Antony VB. Immunobiology of pleural inflammation: potential implications for pathogenesis, diagnosis and therapy. Eur Respir J 1997; 10 (10): 2411-8
13. Idell S, Girard W, Koenig KB, et al. Abnormalities of pathways of fibrin turnover in the human pleural space. Am Rev Respir Dis 1991; 144 (1): 187-94
14. Sahn SA, Reller LB, Taryle DA, et al. The contribution of leukocytes and bacteria to the low pH of empyema fluid. Am Rev Respir Dis 1983; 128 (5): 811-5
15. Maskell NA, Davies CW, Jones E, et al. The characteristics of 300 patients participating in the MRC/BTS multicenter intra-pleural streptokinase vs placebo trial (ISRCTN-39138989). American Thoracic Society Meeting; 2002, Atlanta
16. Perez-Rodriguez E, Jimenez CD, Light RW. Effusions from tuberculosis. In: Light RW, Lee YC, editors. Textbook of pleural disease. London: Arnold, 2003: 329-44
17. Ferrer A, Osset J, Alegre J, et al. Prospective clinical and microbiological study of pleural effusions. Eur J Clin Microbiol Infect Dis 1999; 18 (4): 237-41
18. Bartlett JG, Finegold SM. Anaerobic infections of the lung and pleural space. Am Rev Respir Dis 1974; 110 (1): 56-77
19. Colice GL, Curtis A, Deslauriers J, et al. Medical and surgical treatment of parapneumonic effusions: an evidence-based guideline. Chest 2000; 118 (4): 1158-71
20. Jones PW, Moyers JP, Rogers JT, et al. Ultrasound-guided thoracentesis: is it a safer method? Chest 2003; 123 (2): 418-23
21. O'Moore PV, Mueller PR, Simeone JF, et al. Sonographic guidance in diagnostic and therapeutic interventions in the pleural space. AJR Am J Roentgenol 1987; 149 (1): 1-5
22. Kearney SE, Davies CW, Davies RJ, et al. Computed tomography and ultrasound in parapneumonic effusions and empyema. Clin Radiol 2000; 55 (7): 542-7
23. Aquino SL, Webb WR, Gushiken BJ. Pleural exudates and transudates: diagnosis with contrast-enhanced CT. Radiology 1994; 192 (3): 803-8
24. Stark DD, Federle MP, Goodman PC, et al. Differentiating lung abscess and empyema: radiography and computed tomography. Am J Roentgenol 1983; 141 (1): 163-7
25. Evans AL, Gleeson FV. Radiology in pleural disease: state of the art. Respirology 2004; 9 (3): 300-12
26. Light RW, MacGregor MI, Luchsinger PC, et al. Pleural effusions: the diagnostic separation of transudates and exudates. Ann Intern Med 1972; 77 (4): 507-13
27. 2. Chest 1973; 64 (5): 591-6
28. Heffner JE, Brown LK, Barbieri C, et al. Pleural fluid chemical analysis in parapneumonic effusions: a meta-analysis. Am J Respir Crit Care Med 1995; 151 (6): 1700-8
29. Jimenez CD, Diaz G, Perez-Rodriguez E, et al. Modification of pleural fluid pH by local anesthesia. Chest 1999; 116 (2): 399-402
30. Lesho EP, Roth BJ. Is pH paper an acceptable, low-cost alternative to the blood gas analyzer for determining pleural fluid pH? Chest 1997; 112 (5): 1291-2
31. Porcel JM, Vives M, Esquerda A. Tumor necrosis factor-alpha in pleural fluid: a marker of complicated parapneumonic effusions. Chest 2004; 125 (1): 160-4
32. LeMense GP, Strange C, Sahn SA. Empyema thoracis: therapeutic management and outcome. Chest 1995; 107 (6): 1532-7
33. Davies CW, Kearney SE, Gleeson FV, et al. Predictors of outcome and long-term survival in patients with pleural infection. Am J Respir Crit Care Med 1999; 160 (5 Pt 1): 1682-7
34. Sahn SA. Pleural effusions in the atypical pneumonias. Semin Respir Infect 1988; 3 (4): 322-34
35. Shohet I, Yellin A, Meyerovitch J, et al. Pharmacokinetics and therapeutic efficacy of gentamicin in an experimental pleural empyema rabbit model. Antimicrob Agents Chemother 1987; 31 (7): 982-5
36. Merriam MA, Cronan JJ, Dorfman GS, et al. Radiographically guided percutaneous catheter drainage of pleural fluid collections. Am J Roentgenol 1988; 151 (6): 1113-6
37. Silverman SG, Mueller PR, Saini S, et al. Thoracic empyema: management with image-guided catheter drainage. Radiology 1988; 169 (1): 5-9
38. Stavas J, van Sonnenberg E, Casola G, et al. Percutaneous drainage of infected and noninfected thoracic fluid collections. J Thorac Imaging 1987; 2 (3): 80-7
39. Ulmer JL, Choplin RH, Reed JC. Image-guided catheter drainage of the infected pleural space. J Thorac Imaging 1991; 6 (4): 65-73
40. Antunes G, Neville E, Duffy J, et al. BTS guidelines for the management of malignant pleural effusions. Thorax 2003; 58 Suppl. 2: ii29-38
41. Pothula V, Krellenstein DJ. Early aggressive surgical management of parapneumonic empyemas. Chest 1994; 105 (3): 832-6
42. Tillett WS, Sherry S. The effect in patients of streptococcal fibrinolysin (streptokinase) and streptococcal deoxyribonuclease on fibrinous, purulent and sanguinous pleural exudations. J Clin Invest 1949; 28 (1): 173-90
43. Bouros D, Schiza S, Patsourakis G, et al. Intrapleural streptokinase versus urokinase in the treatment of complicated parapneumonic effusions: a prospective, double-blind study. Am J Respir Crit Care Med 1997; 155 (1): 291-5
44. Bouros D, Schiza S, Tzanakis N, et al. Intrapleural urokinase versus normal saline in the treatment of complicated parapneumonic effusions and empyema: a randomized, double-blind study. Am J Respir Crit Care Med 1999; 159 (1): 37-42
45. Davies RJ, Traill ZC, Gleeson FV. Randomised controlled trial of intrapleural streptokinase in community acquired pleural infection. Thorax 1997; 52 (5): 416-21
46. Diacon AH, Theron J, Schuurmans MM, et al. Intrapleural streptokinase for empyema and complicated parapneumonic effusions. Am J Respir Crit Care Med 2004; 170 (1): 49-53
47. Tuncozgur B, Ustunsoy H, Sivrikoz MC, et al. Intrapleural urokinase in the management of parapneumonic empyema: a randomised controlled trial. Int J Clin Pract 2001; 55 (10): 658-60
48. Cameron R, Davies HR. Intra-pleural fibrinolytic therapy versus conservative management in the treatment of parapneumonic effusions and empyema. Cochrane Database Syst Rev 2004; (2): CD002312
49. Light RW, Nguyen T, Mulligan ME, et al. The in vitro efficacy of varidase versus streptokinase or urokinase for liquefying thick purulent exudative material from loculated empyema. Lung 2000; 178 (1): 13-8
50. Simpson G, Roomes D, Heron M. Effects of streptokinase and deoxyribonuclease on viscosity of human surgical and empyema pus. Chest 2000; 117 (6): 1728-33
51. Fujiwara K, Yasumitsu T, Nakagawa K, et al. Intrapleural streptokinase-streptodornase in the treatment of empyema and hemothorax [in Japanese]. Kyobu Geka 2002; 55 (13): 1115-9
52. Simpson G, Roomes D, Reeves B. Successful treatment of empyema thoracis with human recombinant deoxyribonuclease. Thorax 2003; 58 (4): 365-6
53. Jimenez CD, Diaz G, Perez-Rodriguez E, et al. Prognostic features of residual pleural thickening in parapneumonic pleural effusions. Eur Respir J 2003; 21 (6): 952-5